As the demand for the cold chain market continues to grow, #SkyCell remains proactive in staying ahead of the latest challenges in the pharmaceutical cold chain industry in the APAC region. Last month, we actively participated in major events across the APAC region, including Asia's largest pharmaceutical supply chain event, LogiPharma Asia 2024, as well as the BIOPLUS-INTERPHEX KOREA, INTERPHEX Week Tokyo and CPHI China . These events were filled with vibrant discussions, the exchange of innovative ideas, and the exploration of new possibilities. A huge thank you to all our partners and customers who visited our booths and engaged with our teams. It was truly wonderful reconnecting with so many of you. See you next year! 🤝 #Events #PharmaceuticalIndustry #ColdChain #SupplyChain #APAC
소개
The future of Bio-pharma, through the power of experience.
- 업계
- 이벤트 서비스
- 회사 규모
- 직원 11-50명
- 본사
- Seoul
- 유형
- 비상장기업
위치
업데이트
-
We are grateful for the opportunity to contribute to the panel during BIOPLUS-INTERPHEX KOREA and happy to share more highlights from the event! 📷 Jim Sergi #BIOPLUSINTERPHEX #KoreaBIO #Korea #pharmaceuticals #biopharm #Asia #regulatoryaffairs #funding #medicaldevice
-
-
-
-
-
+4
-
-
👏 THANK YOU We extend our heartfelt gratitude to all our visitors, exhibitors and speakers for making BIX 2024 a resounding success. Your participation and contributions have been invaluable, and we are honored to have shared this experience with such a distinguished group of professionals. Please stay tuned for updates as we prepare for BIX 2025. We look forward to welcoming you next year for another exceptional event filled with innovation, inspiration, and opportunities for growth. Thank you once again for your support and engagement. 💙 BIOPLUS-INTERPHEX KOREA 2025 📅 2025.10.15-2025.10.17 📍 HALL C, COEX
-
-
🌟 Thank You for Visiting Our Booth at BIOPLUS-INTERPHEX KOREA 2024! 🌟 We had an incredible time at the hashtag #BioPlus 2024 conference, and it was all thanks to you! Your enthusiasm, insightful questions, and genuine interest in our work made this event truly special. A heartfelt thank you to everyone who took the time to stop by our booth. It was a pleasure connecting with industry leaders, innovators, and fellow professionals. Your engagement and feedback are invaluable to us as we continue to push the boundaries of innovation and excellence. I also want to express my deep appreciation for the opportunity to speak about Markens' sustainability efforts. Sharing our vision and commitment to a more sustainable future with such a passionate audience was a highlight of the conference for me. During my speech, I introduced our latest initiative, Pharma #OceanColdChain as a Service. For those interested in learning more about this innovative solution, I invite you to read the detailed article published in Yakup News, although in Korean 😀 Link to article about pharma ocean cold chain https://lnkd.in/gYQ93x9i #BioPlus2024 #Innovation #Biotech #Sustainability #MarkenKorea #PharmaOceanColdChain #PharmaSupplyChain #BIX #ClinicaltoCommercial #Pharmalogistics #Gobeyondlogistics
-
-
BIOPLUS-INTERPHEX KOREA 2024 set a new record with over 10,700 visitors, and 232 companies from 15 countries were exhibiting. The Cold Chain is a critical part of the biopharmaceutical industry. Bioplus-Interphex Korea stands out in Korea for its unique offering of a Cold Chain Docent Tour program and a Cold Chain Pavilion. Over 130 individuals participated in the Cold Chain Docent Tour... Read more: https://bit.ly/4f9vsqs #BioplusInterphexKorea #ColdChain #Biopharma #Innovation
-
⚕의료 기술 및 생명 과학 분야에 전문성을 보유한 인트라링크 코리아 (Intralink Korea)가 국내외 바이오 제약 산업의 트렌드를 알아보기 위해 BIOPLUS-INTERPHEX KOREA 2024(BIX 2024)를 방문했습니다! 전 세계 15개국 232개 기업이 참여해 역대 최대 참관객을 모았다는 이번 BIX 2024에서 인트라링크 Medtech & Life Sciences팀이 직접 꼽은 관전 포인트 TOP 3, 과연 어떤 것이 있을까요? 1️⃣ 첫째, 총 449개 부스로 꾸려진 바이오산업 최대 전시인 만큼 제조 및 설비(CRO, CDMO), AI 융합 플랫폼, 실험실 정보 관리 시스템(LIMS), 콜드 체인, 신약 개발 등 다양한 분야의 회사들의 핵심 기술 전시 2️⃣ 둘째, 비만치료제, 세포·유전자 치료제(CGT), 항체·약물 접합체(ADC)을 주제로 한 강연으로 알 수 있는 현 바이오산업의 화두이자 미래 키워드 3️⃣ 셋째, 15만 6천 명의 한국인 혈액 데이터 독점권을 보유한 basgenbio (바스젠바이오), 중간엽줄기세포(MSC) 항암 치료제 개발 기업 셀레브레인 등 국내 혁신 바이오 기술 스타트업들의 약진 지난 10년간, 팬데믹 이후 더욱 급부상한 제약 바이오산업의 글로벌 기술 트렌드, 앞으로도 인트라링크가 놓치지 않고 전하겠습니다.📨👩🔬
-
-
We attended BIOPLUS-INTERPHEX KOREA last week, and it was nice to see many familiar faces again. Thank you Bioplus-Interphex Korea for organising such a great event that allowed us to learn and have valuable exchanges with the Biopharmaceutical and Cold Chain industry partners. Looking forward to a closer collaboration with the industry experts.
-
-
-
-
-
+3
-
-
⚕의료 기술 및 생명 과학 분야에 전문성을 보유한 인트라링크 코리아 (Intralink Korea)가 국내외 바이오 제약 산업의 트렌드를 알아보기 위해 BIOPLUS-INTERPHEX KOREA 2024(BIX 2024)를 방문했습니다! 전 세계 15개국 232개 기업이 참여해 역대 최대 참관객을 모았다는 이번 BIX 2024에서 인트라링크 Medtech & Life Sciences팀이 직접 꼽은 관전 포인트 TOP 3, 과연 어떤 것이 있을까요? 1️⃣ 첫째, 총 449개 부스로 꾸려진 바이오산업 최대 전시인 만큼 제조 및 설비(CRO, CDMO), AI 융합 플랫폼, 실험실 정보 관리 시스템(LIMS), 콜드 체인, 신약 개발 등 다양한 분야의 회사들의 핵심 기술 전시 2️⃣ 둘째, 비만치료제, 세포·유전자 치료제(CGT), 항체·약물 접합체(ADC)을 주제로 한 강연으로 알 수 있는 현 바이오산업의 화두이자 미래 키워드 3️⃣ 셋째, 15만 6천 명의 한국인 혈액 데이터 독점권을 보유한 basgenbio (바스젠바이오), 중간엽줄기세포(MSC) 항암 치료제 개발 기업 셀레브레인 등 국내 혁신 바이오 기술 스타트업들의 약진 지난 10년간, 팬데믹 이후 더욱 급부상한 제약 바이오산업의 글로벌 기술 트렌드, 앞으로도 인트라링크가 놓치지 않고 전하겠습니다.📨👩🔬
-
-
We sincerely thank everyone who connected with us at BIOPLUS-INTERPHEX Korea 2024. We hope for continued discussions that can lead to collaboration opportunities going forward. Check out some highlights from the event. #SamsungBiologics #BIOPLUSINTERPHEX_Korea #CDMO #Biopharma #Partnership
-
-
That’s a Wrap on BIOPLUS-INTERPHEX KOREA 2024!✨ It was a pleasure meeting so many passionate professionals. Thank you to everyone who visited our booth and tried out our cancer diagnostic and biomarker discovery platform solutions. We look forward to seeing you all again at BIOPLUS-INTERPHEX KOREA 2025!👋 #AIVIS #BIOPLUSINTERPHEX2024 #Innovation #AI #CancerDiagnosis #PathologyInnovation #PathologyAI
-